Clinical Pharmacology of Nicotine: Implications for Understanding, Preventing, and Treating Tobacco Addiction

Department of Medicine, University of California, San Francisco, California, USA.
Clinical Pharmacology &#38 Therapeutics (Impact Factor: 7.39). 05/2008; 83(4):531-41. DOI: 10.1038/clpt.2008.3
Source: PubMed

ABSTRACT Understanding the basic and clinical pharmacology of nicotine provides a basis for improved prevention and treatment of tobacco addiction. Nicotine acts on nicotinic cholinergic receptors in the brain to release dopamine and other neurotransmitters that sustain addiction. Neuroadaptation and tolerance involve changes in both nicotinic receptors and neural plasticity. Nicotine addiction can occur in the context of physical dependence characterized by self-medication to modulate negative affect and/or to relieve withdrawal symptoms, as well as, in light or occasional smokers, primarily for positive reinforcement in specific situations. Nicotine is metabolized primarily by CYP2A6. Its clearance exhibits considerable individual variability that is determined by genetic, racial, and hormonal (sex) factors. Genetically slow metabolism of nicotine appears to be associated with a lower level of dependence. Nicotine dependence is highly heritable and appears to be influenced by genes coding for some nicotine receptor subtypes, some neurotransmitter genes, and genes involved in neural connectivity. Novel pharmacotherapies for nicotine dependence include partial agonists for nicotinic receptors and nicotine vaccines. Pharmacogenetic studies suggest various candidate genes and a nicotine metabolism phenotype that influence outcome. Human pharmacology studies of nicotine and smoking behavior also provide a basis for assessing the benefits and risks of long-term nicotine use for harm reduction and for a potential cigarette regulatory strategy that includes reducing nicotine content of cigarettes to nonaddictive levels.

  • [Show abstract] [Hide abstract]
    ABSTRACT: In recent decades, addiction has been medicalized anew through the rise of an influential ‘brain disease paradigm’. This questions the equivalence of addiction to drug dependence by re-emphasizing loss of self-control over unhealthy impulses as the disease locus. While showing continuities with the nineteenth-century vision of addictions as ‘diseases of the will’, neurobiology objectifies disease as disrupted neurochemical transmission and lasting neuroadaptation. The brain disease paradigm emerged together with rapid advances in neuroimaging technology as well as intensified research efforts to confirm cigarette smoking as nicotine addiction. After smoking achieved such recognition in the late 1980s, numerous other unhealthy impulses and appetites have likewise come under neurobiological investigation as prospective cases of addiction. Despite its technoscientific sophistication, neurobiology's biomedicalization of addiction remains as partial and ambiguous as past medicalizations. By confirming moral self-transformation anew as an indispensable component of treatment and recovery, neurobiology revives addiction as a moral disease in the process of its objectification. Furthermore, through its rediscovery of a classic nineteenth-century ‘liberal disease’ at the molecular level, the neurobiology of addiction is acting as a vital moralizing resource in the biomedicalization of health and illness more generally today.
    Science as Culture 10/2014; 24(1):1-19. DOI:10.1080/09505431.2014.936373 · 0.37 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: RESUMEN. La adicción es un trastorno multifactorial que involucra el consumo compulsivo de sustancias a pesar de las consecuencias negativas asociadas y que se caracteriza por múltiples recaídas. El presente trabajo es una revisión acerca de los mecanismos de acción de algunas drogas de abuso, donde se señalan las simili-tudes entre los procesos adictivos y los mnemónicos. Las sustancias de abuso ejercen sus acciones a través de diferentes mecanismos y sistemas de neurotransmisión y pueden producir cambios estructurales de largo plazo en el cerebro. En los últimos años, se ha estudiado a la adicción como un aprendizaje patológico en el que las drogas utilizan las mismas vías que las recompensas naturales para perpetuar su consumo. El paciente adicto aprende y crea asociaciones entre el consumo de drogas y estados gratificantes que se consolidan en memorias duraderas incluso cuando se desarrolla tolerancia a dichos efectos. La adicción y la memoria comparten meca-nismos celulares, moleculares y epigenéticos. Su comprensión puede mejorar la eficacia de las intervenciones terapéuticas. Palabras clave: Adicciones, drogas de abuso, epigenética, memoria. ABSTRACT. Drug addiction is a multifactorial disorder that involves compulsive substance use despite negative consequences, and is characterized by frequent relapses. This paper reviews the mechanisms of action of some drugs of abuse, showing the similarities between addictive and mnemonic processes. Drugs of abuse exert their actions through different mechanisms and neurotransmitter systems and may cause long-term structural changes in the brain. In recent years, addiction has been studied as a pathological condition in which drugs act through the same pathways that are used by natural rewards to perpetuate their use. The addicted patient learns and creates associations between drug use and rewarding effects that are consolidated into long-lasting memories even when tolerance develops to these effects. Addiction and memory share cellular , molecular and epigenetic mechanisms. Their understanding can improve therapeutic intervention efficacy. Este artículo puede ser consultado en versión completa en
  • Seminars in Roentgenology 04/2015; 50(2):72-81. DOI:10.1053/ · 1.18 Impact Factor


Available from